Flux Optimization in Human Specific Map-Kinase Pathways: A Systems Biology Approach to Study Cancer

被引:0
|
作者
Sahu, Sombeet [1 ]
机构
[1] Natl Inst Technol, Dept Biotechnol, Durgapur 713209, India
关键词
Systems biology; MAP Kinase; Flux Optimization; Signal Transduction Networks; METABOLIC GENOTYPE; NETWORKS;
D O I
10.1063/1.3516321
中图分类号
TP39 [计算机的应用];
学科分类号
081203 ; 0835 ;
摘要
Mitogen-Activated Protein Kinase (MAP kinases) transduces signals that are involved in a multitude of cellular pathways and functions in response to variety of ligands and cell stimuli. Aberrant or inappropriate functions of MAPKs have now been identified in diseases ranging from Cancer to Alzheimer disease to Leshmaniasis however the pathway is still growing and little is known about the dynamics of the pathway. Here we model the MAPK metabolic pathways and thus find the key metabolites or reactions involved on perturbing which the transcription factors are affected. The approach, which we used for modeling of this pathway, is Flux Balance Analysis (FBA). Further we established the growth factors EGF, PDGF were also responsible for the determination of downstream species concentrations. Tuning the parameters gave the optimum kinetics of the growth factor for which the downstream events were at the minimum. Also the Ras and Braf steady state concentrations were significantly affected when the Growth factor kinetics were tuned. This type of study can shed light on controlling various diseases and also may be helpful for identifying important drug targets.
引用
收藏
页码:313 / 318
页数:6
相关论文
共 49 条
  • [1] CELL BIOLOGY - 2 MAJOR SIGNALING PATHWAYS MEET AT MAP-KINASE
    BARINAGA, M
    SCIENCE, 1995, 269 (5231) : 1673 - 1673
  • [2] Interaction between the bone morphogenetic proteins and Ras/MAP-kinase signalling pathways in lung cancer
    K S Kraunz
    H H Nelson
    M Liu
    J K Wiencke
    K T Kelsey
    British Journal of Cancer, 2005, 93 : 949 - 952
  • [3] Interaction between the bone morphogenetic proteins and Ras/MAP-kinase signalling pathways in lung cancer
    Kraunz, KS
    Nelson, HH
    Liu, M
    Wiencke, JK
    Kelsey, KT
    BRITISH JOURNAL OF CANCER, 2005, 93 (08) : 949 - 952
  • [4] ASSESSMENT OF PI3-KINASE, MAP-KINASE AND WNT DEPENDENT PATHWAYS TO HELP RISK-STRATIFY PATIENTS WITH PROSTATE CANCER
    Jefferies, Matthew
    Cox, Adam
    Kynaston, Howard
    Clarke, Alan
    ANTICANCER RESEARCH, 2015, 35 (07) : 4364 - 4365
  • [5] Human pre-B cell receptor signal transduction: evidence for distinct roles of PI3kinase and MAP-kinase signalling pathways
    Anbazhagan, Kolandaswamy
    Singh, Amrathlal Rabbind
    Isabelle, Piec
    Stella, Ibata
    Celine, Alleaume-De Martel
    Bissac, Eliane
    Bertrand, Brassart
    Remy, Nyga
    Naomi, Taylor
    Vincent, Fuentes
    Rochette, Jacques
    Lassoued, Kaiss
    IMMUNITY INFLAMMATION AND DISEASE, 2013, 1 (01): : 26 - 36
  • [6] A Systems Biology Approach To Identify Proliferative Biomarkers and Pathways In Breast Cancer
    Agarwal, Devika
    Kergosien, Marie
    Boocock, David J.
    Rees, Robert C.
    Ball, Graham R.
    2014 IEEE INTERNATIONAL CONFERENCE ON BIOINFORMATICS AND BIOMEDICINE (BIBM), 2014,
  • [7] Elucidating the biosynthetic pathways of human milk oligosaccharides through a systems biology approach
    Lewis, Nathan
    Richelle, Anne
    Kellman, Benjamin
    FASEB JOURNAL, 2020, 34
  • [8] The role of ERK 1/2 and p38 MAP-kinase pathways in Taxol-induced apoptosis in human ovarian carcinoma cells
    Seidman, R
    Gitelman, I
    Sagi, O
    Horwitz, SB
    Wolfson, M
    EXPERIMENTAL CELL RESEARCH, 2001, 268 (01) : 84 - 92
  • [9] Targeting the TNF network in human ovarian cancer - A systems biology approach
    Kulbe, Hagen
    Chakravarty, Probir
    Moore, Robert
    Iorio, Francesco
    Montoya, Alexander
    Saez-Rodriguez, Julio
    Cutillas, Pedro
    Balkwill, Frances
    CANCER RESEARCH, 2012, 72
  • [10] Introducing Potential Key Proteins and Pathways in Human Laryngeal Cancer: A System Biology Approach
    Peyvandi, Hassan
    Peyvandi, Ali Asghar
    Safaei, Akram
    Azodi, Mona Zamanian
    Rezaei-Tavirani, Mostafa
    IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH, 2018, 17 (01): : 415 - 425